Loading…

Bone metabolism during long-term treatment with imatinib

Saved in:

Bibliographic Details
Published in:	Leukemia & lymphoma 2013-08, Vol.54 (8), p.1783-1785
Main Authors:	O'Sullivan, Susannah, Horne, Anne, Wattie, Diana, Porteous, Fran, Gamble, Greg, Browett, Peter, Grey, Andrew
Format:	Article
Language:	English
Subjects:	Adult Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Benzamides - pharmacology Benzamides - therapeutic use Biomarkers Bone and Bones - drug effects Bone and Bones - metabolism Bone Density Female Follow-Up Studies Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism Male Middle Aged Piperazines - pharmacology Piperazines - therapeutic use Protein Kinase Inhibitors - pharmacology Protein Kinase Inhibitors - therapeutic use Pyrimidines - pharmacology Pyrimidines - therapeutic use
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!